Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells
Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART. We reasoned that molecular dynamics at the CART immune synapse (CARIS) could explain differences in their tumor...
Saved in:
| Published in | Science advances Vol. 11; no. 2; p. eadq8114 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
10.01.2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2375-2548 2375-2548 |
| DOI | 10.1126/sciadv.adq8114 |
Cover
| Abstract | Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART. We reasoned that molecular dynamics at the CART immune synapse (CARIS) could explain differences in their tumor rejection kinetics. We observed that CD28.ζ-CART engaged in brief highly lethal CARIS and mastered serial killing, whereas 4-1BB.ζ-CART formed lengthy CARIS and relied on robust expansion and cooperative killing. We analyzed CARIS membrane lipid rafts (mLRs) and found that, upon tumor engagement, CD28.ζ-CAR molecules rapidly but transiently translocated into mLRs, mobilizing the microtubular organizing center and lytic granules to the CARIS. This enabled fast CART recovery and sensitivity to low target site density. In contrast, gradual accumulation of 4-1BB.ζ-CAR and LFA-1 molecules at mLRs built mechanically tonic CARIS mediating chronic Fas ligand–based killing. The differences in CD28.ζ- and 4-1BB.ζ-CARIS dynamics explain the distinct cytolytic behavior of CART and can guide engineering of more adaptive effective cellular products.
CAR signaling domains determine molecular dynamics at the immune synapse and consequently influence CAR T cell killing behavior. |
|---|---|
| AbstractList | Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART. We reasoned that molecular dynamics at the CART immune synapse (CARIS) could explain differences in their tumor rejection kinetics. We observed that CD28.ζ-CART engaged in brief highly lethal CARIS and mastered serial killing, whereas 4-1BB.ζ-CART formed lengthy CARIS and relied on robust expansion and cooperative killing. We analyzed CARIS membrane lipid rafts (mLRs) and found that, upon tumor engagement, CD28.ζ-CAR molecules rapidly but transiently translocated into mLRs, mobilizing the microtubular organizing center and lytic granules to the CARIS. This enabled fast CART recovery and sensitivity to low target site density. In contrast, gradual accumulation of 4-1BB.ζ-CAR and LFA-1 molecules at mLRs built mechanically tonic CARIS mediating chronic Fas ligand-based killing. The differences in CD28.ζ- and 4-1BB.ζ-CARIS dynamics explain the distinct cytolytic behavior of CART and can guide engineering of more adaptive effective cellular products. Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART. We reasoned that molecular dynamics at the CART immune synapse (CARIS) could explain differences in their tumor rejection kinetics. We observed that CD28.ζ-CART engaged in brief highly lethal CARIS and mastered serial killing, whereas 4-1BB.ζ-CART formed lengthy CARIS and relied on robust expansion and cooperative killing. We analyzed CARIS membrane lipid rafts (mLRs) and found that, upon tumor engagement, CD28.ζ-CAR molecules rapidly but transiently translocated into mLRs, mobilizing the microtubular organizing center and lytic granules to the CARIS. This enabled fast CART recovery and sensitivity to low target site density. In contrast, gradual accumulation of 4-1BB.ζ-CAR and LFA-1 molecules at mLRs built mechanically tonic CARIS mediating chronic Fas ligand-based killing. The differences in CD28.ζ- and 4-1BB.ζ-CARIS dynamics explain the distinct cytolytic behavior of CART and can guide engineering of more adaptive effective cellular products.Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART. We reasoned that molecular dynamics at the CART immune synapse (CARIS) could explain differences in their tumor rejection kinetics. We observed that CD28.ζ-CART engaged in brief highly lethal CARIS and mastered serial killing, whereas 4-1BB.ζ-CART formed lengthy CARIS and relied on robust expansion and cooperative killing. We analyzed CARIS membrane lipid rafts (mLRs) and found that, upon tumor engagement, CD28.ζ-CAR molecules rapidly but transiently translocated into mLRs, mobilizing the microtubular organizing center and lytic granules to the CARIS. This enabled fast CART recovery and sensitivity to low target site density. In contrast, gradual accumulation of 4-1BB.ζ-CAR and LFA-1 molecules at mLRs built mechanically tonic CARIS mediating chronic Fas ligand-based killing. The differences in CD28.ζ- and 4-1BB.ζ-CARIS dynamics explain the distinct cytolytic behavior of CART and can guide engineering of more adaptive effective cellular products. Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor control exhibited by 4-1BB.ζ-CART. We reasoned that molecular dynamics at the CART immune synapse (CARIS) could explain differences in their tumor rejection kinetics. We observed that CD28.ζ-CART engaged in brief highly lethal CARIS and mastered serial killing, whereas 4-1BB.ζ-CART formed lengthy CARIS and relied on robust expansion and cooperative killing. We analyzed CARIS membrane lipid rafts (mLRs) and found that, upon tumor engagement, CD28.ζ-CAR molecules rapidly but transiently translocated into mLRs, mobilizing the microtubular organizing center and lytic granules to the CARIS. This enabled fast CART recovery and sensitivity to low target site density. In contrast, gradual accumulation of 4-1BB.ζ-CAR and LFA-1 molecules at mLRs built mechanically tonic CARIS mediating chronic Fas ligand–based killing. The differences in CD28.ζ- and 4-1BB.ζ-CARIS dynamics explain the distinct cytolytic behavior of CART and can guide engineering of more adaptive effective cellular products. CAR signaling domains determine molecular dynamics at the immune synapse and consequently influence CAR T cell killing behavior. |
| Author | Srinivasan, Madhuwanti Lee, Jessica C. H. Leen, Ann M. Li, Yongshuai Carisey, Alexandre Berger, Harrison Sheha, Mohamed F. Kerr, Sybrina S. Saeedi, Arash R. Levental, Kandice Gad, Ahmed Z. Brock, Rebecca M. Joseph, Sujith K. Abu-Arja, Mohammad H. Levental, Ilya Hegde, Meenakshi Varadarajan, Navin Godret-Miertschin, Lea Fousek, Kristen Mukherjee, Malini Montalvo, Melisa J. Morris, Jessica S. Mamonkin, Maksim Saadeldin, Amr M. Ahmed, Nabil Vasileiou, Spyridoula Xu, Shuo |
| Author_xml | – sequence: 1 givenname: Ahmed Z. orcidid: 0000-0002-6149-3414 surname: Gad fullname: Gad, Ahmed Z. organization: Interdepartmental Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA., Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 2 givenname: Jessica S. orcidid: 0000-0002-2026-1297 surname: Morris fullname: Morris, Jessica S. organization: Interdepartmental Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA., Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 3 givenname: Lea surname: Godret-Miertschin fullname: Godret-Miertschin, Lea organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 4 givenname: Melisa J. orcidid: 0009-0008-9395-6998 surname: Montalvo fullname: Montalvo, Melisa J. organization: William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204, USA – sequence: 5 givenname: Sybrina S. orcidid: 0009-0003-6616-9909 surname: Kerr fullname: Kerr, Sybrina S. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Immunology & Microbiology Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 6 givenname: Harrison orcidid: 0009-0005-6668-9191 surname: Berger fullname: Berger, Harrison organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 7 givenname: Jessica C. H. orcidid: 0009-0001-7318-4598 surname: Lee fullname: Lee, Jessica C. H. organization: Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Texas Children’s Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA – sequence: 8 givenname: Amr M. surname: Saadeldin fullname: Saadeldin, Amr M. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Development, Disease Models & Therapeutics Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 9 givenname: Mohammad H. orcidid: 0000-0003-4606-2269 surname: Abu-Arja fullname: Abu-Arja, Mohammad H. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 10 givenname: Shuo surname: Xu fullname: Xu, Shuo organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 11 givenname: Spyridoula orcidid: 0000-0002-7970-9391 surname: Vasileiou fullname: Vasileiou, Spyridoula organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 12 givenname: Rebecca M. orcidid: 0000-0003-4022-6189 surname: Brock fullname: Brock, Rebecca M. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 13 givenname: Kristen orcidid: 0000-0002-2307-5000 surname: Fousek fullname: Fousek, Kristen organization: Interdepartmental Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA., Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 14 givenname: Mohamed F. orcidid: 0000-0002-2101-5872 surname: Sheha fullname: Sheha, Mohamed F. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 15 givenname: Madhuwanti surname: Srinivasan fullname: Srinivasan, Madhuwanti organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 16 givenname: Yongshuai surname: Li fullname: Li, Yongshuai organization: William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204, USA – sequence: 17 givenname: Arash surname: Saeedi fullname: Saeedi, Arash organization: William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204, USA – sequence: 18 givenname: Kandice orcidid: 0000-0002-2234-3683 surname: R. Levental fullname: R. Levental, Kandice organization: Department of Molecular Physiology and Biological Physics, Center for Molecular and Cell Physiology, University of Virginia, Charlottesville, VA 22903, USA – sequence: 19 givenname: Ann M. surname: Leen fullname: Leen, Ann M. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 20 givenname: Maksim orcidid: 0000-0001-7178-8163 surname: Mamonkin fullname: Mamonkin, Maksim organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 21 givenname: Alexandre orcidid: 0000-0003-1326-2205 surname: Carisey fullname: Carisey, Alexandre organization: Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Texas Children’s Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA – sequence: 22 givenname: Navin orcidid: 0000-0001-7524-8228 surname: Varadarajan fullname: Varadarajan, Navin organization: William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204, USA – sequence: 23 givenname: Meenakshi orcidid: 0000-0002-7778-7871 surname: Hegde fullname: Hegde, Meenakshi organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 24 givenname: Sujith K. orcidid: 0000-0003-4596-1270 surname: Joseph fullname: Joseph, Sujith K. organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 25 givenname: Ilya orcidid: 0000-0002-1206-9545 surname: Levental fullname: Levental, Ilya organization: Department of Molecular Physiology and Biological Physics, Center for Molecular and Cell Physiology, University of Virginia, Charlottesville, VA 22903, USA – sequence: 26 givenname: Malini surname: Mukherjee fullname: Mukherjee, Malini organization: Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Texas Children’s Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA – sequence: 27 givenname: Nabil orcidid: 0000-0002-0982-8424 surname: Ahmed fullname: Ahmed, Nabil organization: Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39792660$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kE1LAzEQhoNUbK29epQcvWxNdrNfx1L8goog9RyzySyNZDdtki3sv3dLWxDB0wzD8w4zzzUatbYFhG4pmVMaZw9eaqH2c6F2BaXsAk3iJE-jOGXF6Fc_RjPvvwkhlGVZSssrNE7KvIyzjEzQ15s1IDsjHFZ9KxotPRYB66bpWsB-GG09YKO3WmEn6uCxbmvTQSsBhw1g2Qdr-qAlrmAj9to6bGu8XHzgNZZgjL9Bl7UwHmanOkWfT4_r5Uu0en9-XS5WkUySNERAyuGllNUga5qxPKkpJQWVVUVyxipIhBKKqpzJnKhS5mXBGAEgVVVUAFmZTNH9ce_W2V0HPvBG-8MFogXbeZ7QlFFWpJQM6N0J7aoGFN863QjX87OVAWBHQDrrvYOaSx1E0LYNTmjDKeEH__zon5_8D7H5n9h58z-BH5vuiso |
| CitedBy_id | crossref_primary_10_1016_j_canlet_2025_217542 |
| Cites_doi | 10.1146/annurev.iy.05.040187.001255 10.1101/cshperspect.a002436 10.1038/s41590-020-0719-0 10.1158/2159-8290.CD-19-0945 10.1038/d41573-022-00095-1 10.1158/0008-5472.CAN-06-4309 10.1080/08830180600743081 10.1046/j.1365-2567.2003.01578.x 10.1172/JCI83416 10.1016/j.celrep.2017.09.015 10.1083/jcb.200207096 10.1194/jlr.D800037-JLR200 10.1158/2326-6066.CIR-17-0126 10.1182/bloodadvances.2022009462 10.1158/2326-6066.CIR-14-0161 10.1038/s41467-021-25189-z 10.1126/sciadv.abg4485 10.1126/sciimmunol.abd4344 10.4049/jimmunol.173.5.2960 10.1038/ni.2033 10.1158/2326-6066.CIR-15-0048 10.1158/2767-9764.CRC-23-0424 10.1158/0008-5472.CAN-20-2701 10.1182/bloodadvances.2019000525 10.4049/jimmunol.208.Supp.179.20 10.1074/jbc.274.38.26869 10.1016/S0021-9258(20)80597-3 10.1016/j.cellimm.2008.08.007 10.1038/emboj.2009.6 10.1126/scisignal.aay8248 10.1038/s41571-023-00754-1 10.1016/j.ccell.2023.11.011 10.1080/19420862.2019.1688616 10.1074/jbc.M112417200 10.1126/sciimmunol.adf1426 10.1126/science.283.5402.680 10.1242/jcs.00606 10.1038/s41586-021-04390-6 10.1073/pnas.1008663107 10.1038/nri.2016.54 10.1016/j.ccell.2019.12.014 10.1038/385083a0 10.1084/jem.20181454 10.1016/j.omto.2019.08.002 10.1038/ncb1492 10.1385/1-59745-048-0:181 10.1038/s41419-024-06461-8 10.1038/ni.1723 10.1016/S2352-3026(21)00238-6 10.1084/jem.20011868 10.4049/jimmunol.169.9.4882 10.1016/j.ymthe.2017.06.003 10.1016/j.bpj.2023.09.004 10.1038/341619a0 10.1172/JCI85309 10.1016/j.immuni.2016.01.021 10.1126/scitranslmed.aac5415 10.1038/ni.2120 10.1056/NEJMoa1709919 10.1038/s41571-021-00530-z 10.1016/j.jtct.2023.10.017 10.1016/j.omto.2020.06.018 10.1016/j.ceb.2011.10.004 10.1083/jcb.200505047 10.1016/j.ccell.2021.12.005 10.1074/jbc.M112.386045 10.1038/s41590-023-01572-4 10.1126/scisignal.aat6753 10.1038/nrd4597 10.1083/jcb.202205118 10.1038/s41591-019-0549-5 10.1093/bioinformatics/bty676 10.1038/nm.3838 10.1016/S0092-8674(02)01257-6 10.1016/S1097-2765(04)00204-7 10.1084/jem.20182375 10.1016/j.cell.2023.02.039 10.1038/mt.2015.199 10.1073/pnas.2216352120 10.1073/pnas.2203247119 10.1073/pnas.232058599 10.1056/NEJMoa1407222 10.1038/srep10082 10.1172/JCI159402 10.1038/s41587-023-01687-x 10.1038/s41467-021-25282-3 10.1158/1535-7163.MCT-19-1109 10.4049/jimmunol.174.4.1898 10.1158/0008-5472.CAN-15-0159 10.1084/jem.190.5.617 10.1126/scitranslmed.3008226 10.1038/s41586-022-04585-5 10.1016/S0140-6736(14)61403-3 10.1002/cpt.2040 10.1038/d41573-021-00100-z 10.1002/psp4.12388 10.1073/pnas.1716266115 10.1038/s41586-019-1054-1 10.1038/nature17412 10.1126/scitranslmed.3005930 10.1038/s41375-020-0792-2 10.1083/jcb.201406121 10.1126/science.abp8933 10.1038/88765 10.1083/jcb.139.3.759 10.1158/0008-5472.CAN-15-0139 10.1016/j.jtct.2022.09.006 10.4049/jimmunol.169.6.2837 10.1158/1078-0432.CCR-18-0758 10.1016/j.ccell.2015.09.004 10.1038/s41417-023-00593-3 10.4049/jimmunol.173.9.5392 10.1126/scitranslmed.abh1962 10.1016/j.ccell.2022.04.001 10.1006/bbrc.1997.8016 10.1038/s41591-022-01959-0 10.1128/MCB.00160-10 10.1038/s41375-022-01585-2 10.1172/jci.insight.99048 10.1038/sj.icb.7100045 10.1038/ncomms16001 10.1083/jcb.141.4.929 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1126/sciadv.adq8114 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| EISSN | 2375-2548 |
| ExternalDocumentID | 39792660 10_1126_sciadv_adq8114 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R01 GM143243 |
| GroupedDBID | 53G 5VS AAFWJ AAYXX ACGFS ADAXU ADBBV ADPDF AENVI AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BCGUY BCNDV BKF CITATION EBS FRP GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 OVD OVEED RHI RPM TEORI CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c335t-e0911254fecf16473f11081cbb0744be3adad1d74c70d9c798440ee0bb8bee693 |
| IEDL.DBID | M48 |
| ISSN | 2375-2548 |
| IngestDate | Fri Jul 11 03:22:21 EDT 2025 Mon Jul 21 05:50:55 EDT 2025 Tue Jul 01 03:12:07 EDT 2025 Thu Apr 24 22:59:04 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c335t-e0911254fecf16473f11081cbb0744be3adad1d74c70d9c798440ee0bb8bee693 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2026-1297 0000-0002-7778-7871 0009-0005-6668-9191 0000-0001-7178-8163 0000-0003-4022-6189 0000-0002-2101-5872 0009-0008-9395-6998 0000-0003-1326-2205 0009-0003-6616-9909 0000-0002-1206-9545 0000-0002-2307-5000 0000-0001-7524-8228 0000-0002-6149-3414 0000-0002-7970-9391 0000-0002-0982-8424 0000-0003-4596-1270 0009-0001-7318-4598 0000-0002-2234-3683 0000-0003-4606-2269 |
| OpenAccessLink | https://doi.org/10.1126/sciadv.adq8114 |
| PMID | 39792660 |
| PQID | 3154148510 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3154148510 pubmed_primary_39792660 crossref_citationtrail_10_1126_sciadv_adq8114 crossref_primary_10_1126_sciadv_adq8114 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-01-10 2025-Jan-10 20250110 |
| PublicationDateYYYYMMDD | 2025-01-10 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-10 day: 10 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Science advances |
| PublicationTitleAlternate | Sci Adv |
| PublicationYear | 2025 |
| References | e_1_3_2_28_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_85_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_89_2 e_1_3_2_100_2 e_1_3_2_123_2 e_1_3_2_104_2 e_1_3_2_81_2 e_1_3_2_108_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_31_2 e_1_3_2_73_2 e_1_3_2_12_2 e_1_3_2_58_2 e_1_3_2_96_2 e_1_3_2_3_2 e_1_3_2_35_2 e_1_3_2_77_2 e_1_3_2_112_2 e_1_3_2_92_2 e_1_3_2_50_2 e_1_3_2_116_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_86_2 e_1_3_2_21_2 e_1_3_2_63_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_67_2 e_1_3_2_82_2 e_1_3_2_103_2 e_1_3_2_122_2 e_1_3_2_107_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_74_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_78_2 e_1_3_2_97_2 e_1_3_2_2_2 e_1_3_2_93_2 e_1_3_2_115_2 e_1_3_2_70_2 e_1_3_2_111_2 e_1_3_2_119_2 e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_87_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_60_2 e_1_3_2_83_2 e_1_3_2_102_2 e_1_3_2_121_2 e_1_3_2_106_2 Liadi I. (e_1_3_2_125_2) 2013; 72 e_1_3_2_9_2 e_1_3_2_37_2 e_1_3_2_18_2 e_1_3_2_75_2 e_1_3_2_10_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_33_2 e_1_3_2_79_2 e_1_3_2_14_2 e_1_3_2_56_2 e_1_3_2_98_2 e_1_3_2_114_2 e_1_3_2_94_2 e_1_3_2_71_2 e_1_3_2_110_2 e_1_3_2_90_2 e_1_3_2_118_2 e_1_3_2_27_2 e_1_3_2_65_2 e_1_3_2_42_2 e_1_3_2_84_2 e_1_3_2_23_2 e_1_3_2_69_2 e_1_3_2_46_2 e_1_3_2_88_2 e_1_3_2_61_2 e_1_3_2_120_2 e_1_3_2_80_2 e_1_3_2_101_2 e_1_3_2_109_2 e_1_3_2_105_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_76_2 e_1_3_2_99_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_95_2 e_1_3_2_4_2 e_1_3_2_91_2 e_1_3_2_113_2 e_1_3_2_72_2 Hernan R. (e_1_3_2_124_2) 2003; 63 e_1_3_2_117_2 |
| References_xml | – ident: e_1_3_2_81_2 doi: 10.1146/annurev.iy.05.040187.001255 – ident: e_1_3_2_94_2 doi: 10.1101/cshperspect.a002436 – ident: e_1_3_2_52_2 doi: 10.1038/s41590-020-0719-0 – ident: e_1_3_2_24_2 doi: 10.1158/2159-8290.CD-19-0945 – ident: e_1_3_2_3_2 doi: 10.1038/d41573-022-00095-1 – ident: e_1_3_2_123_2 doi: 10.1158/0008-5472.CAN-06-4309 – ident: e_1_3_2_44_2 doi: 10.1080/08830180600743081 – ident: e_1_3_2_121_2 doi: 10.1046/j.1365-2567.2003.01578.x – ident: e_1_3_2_51_2 doi: 10.1172/JCI83416 – ident: e_1_3_2_114_2 doi: 10.1016/j.celrep.2017.09.015 – ident: e_1_3_2_72_2 doi: 10.1083/jcb.200207096 – ident: e_1_3_2_75_2 doi: 10.1194/jlr.D800037-JLR200 – ident: e_1_3_2_88_2 doi: 10.1158/2326-6066.CIR-17-0126 – ident: e_1_3_2_16_2 doi: 10.1182/bloodadvances.2022009462 – ident: e_1_3_2_47_2 doi: 10.1158/2326-6066.CIR-14-0161 – ident: e_1_3_2_109_2 doi: 10.1038/s41467-021-25189-z – ident: e_1_3_2_86_2 doi: 10.1126/sciadv.abg4485 – ident: e_1_3_2_67_2 doi: 10.1126/sciimmunol.abd4344 – ident: e_1_3_2_59_2 doi: 10.4049/jimmunol.173.5.2960 – ident: e_1_3_2_91_2 doi: 10.1038/ni.2033 – ident: e_1_3_2_111_2 doi: 10.1158/2326-6066.CIR-15-0048 – ident: e_1_3_2_20_2 doi: 10.1158/2767-9764.CRC-23-0424 – ident: e_1_3_2_23_2 doi: 10.1158/0008-5472.CAN-20-2701 – ident: e_1_3_2_26_2 doi: 10.1182/bloodadvances.2019000525 – ident: e_1_3_2_39_2 doi: 10.4049/jimmunol.208.Supp.179.20 – ident: e_1_3_2_79_2 doi: 10.1074/jbc.274.38.26869 – ident: e_1_3_2_82_2 doi: 10.1016/S0021-9258(20)80597-3 – ident: e_1_3_2_92_2 doi: 10.1016/j.cellimm.2008.08.007 – ident: e_1_3_2_63_2 doi: 10.1038/emboj.2009.6 – ident: e_1_3_2_98_2 doi: 10.1126/scisignal.aay8248 – ident: e_1_3_2_18_2 doi: 10.1038/s41571-023-00754-1 – ident: e_1_3_2_32_2 doi: 10.1016/j.ccell.2023.11.011 – ident: e_1_3_2_37_2 doi: 10.1080/19420862.2019.1688616 – ident: e_1_3_2_83_2 doi: 10.1074/jbc.M112417200 – ident: e_1_3_2_38_2 doi: 10.1126/sciimmunol.adf1426 – ident: e_1_3_2_56_2 doi: 10.1126/science.283.5402.680 – ident: e_1_3_2_119_2 doi: 10.1242/jcs.00606 – volume: 63 start-page: 140 year: 2003 ident: e_1_3_2_124_2 article-title: ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma publication-title: Cancer Res. – volume: 72 start-page: e50058 year: 2013 ident: e_1_3_2_125_2 article-title: Quantitative high-throughput single-cell cytotoxicity assay for T cells publication-title: J. Vis. Exp. – ident: e_1_3_2_14_2 doi: 10.1038/s41586-021-04390-6 – ident: e_1_3_2_87_2 doi: 10.1073/pnas.1008663107 – ident: e_1_3_2_46_2 doi: 10.1038/nri.2016.54 – ident: e_1_3_2_50_2 doi: 10.1016/j.ccell.2019.12.014 – ident: e_1_3_2_90_2 doi: 10.1038/385083a0 – ident: e_1_3_2_93_2 doi: 10.1084/jem.20181454 – ident: e_1_3_2_8_2 doi: 10.1016/j.omto.2019.08.002 – ident: e_1_3_2_61_2 doi: 10.1038/ncb1492 – ident: e_1_3_2_74_2 doi: 10.1385/1-59745-048-0:181 – ident: e_1_3_2_115_2 doi: 10.1038/s41419-024-06461-8 – ident: e_1_3_2_118_2 doi: 10.1038/ni.1723 – ident: e_1_3_2_10_2 doi: 10.1016/S2352-3026(21)00238-6 – ident: e_1_3_2_57_2 doi: 10.1084/jem.20011868 – ident: e_1_3_2_97_2 doi: 10.4049/jimmunol.169.9.4882 – ident: e_1_3_2_49_2 doi: 10.1016/j.ymthe.2017.06.003 – ident: e_1_3_2_43_2 doi: 10.1016/j.bpj.2023.09.004 – ident: e_1_3_2_84_2 doi: 10.1038/341619a0 – ident: e_1_3_2_68_2 doi: 10.1172/JCI85309 – ident: e_1_3_2_99_2 doi: 10.1016/j.immuni.2016.01.021 – ident: e_1_3_2_13_2 doi: 10.1126/scitranslmed.aac5415 – ident: e_1_3_2_112_2 doi: 10.1038/ni.2120 – ident: e_1_3_2_11_2 doi: 10.1056/NEJMoa1709919 – ident: e_1_3_2_5_2 doi: 10.1038/s41571-021-00530-z – ident: e_1_3_2_19_2 doi: 10.1016/j.jtct.2023.10.017 – ident: e_1_3_2_25_2 doi: 10.1016/j.omto.2020.06.018 – ident: e_1_3_2_80_2 doi: 10.1016/j.ceb.2011.10.004 – ident: e_1_3_2_58_2 doi: 10.1083/jcb.200505047 – ident: e_1_3_2_21_2 doi: 10.1016/j.ccell.2021.12.005 – ident: e_1_3_2_105_2 doi: 10.1074/jbc.M112.386045 – ident: e_1_3_2_116_2 doi: 10.1038/s41590-023-01572-4 – ident: e_1_3_2_76_2 doi: 10.1126/scisignal.aat6753 – ident: e_1_3_2_31_2 doi: 10.1038/nrd4597 – ident: e_1_3_2_108_2 doi: 10.1083/jcb.202205118 – ident: e_1_3_2_34_2 doi: 10.1038/s41591-019-0549-5 – ident: e_1_3_2_65_2 doi: 10.1093/bioinformatics/bty676 – ident: e_1_3_2_77_2 doi: 10.1038/nm.3838 – ident: e_1_3_2_110_2 doi: 10.1016/S0092-8674(02)01257-6 – ident: e_1_3_2_89_2 doi: 10.1016/S1097-2765(04)00204-7 – ident: e_1_3_2_101_2 doi: 10.1084/jem.20182375 – ident: e_1_3_2_2_2 doi: 10.1016/j.cell.2023.02.039 – ident: e_1_3_2_22_2 doi: 10.1038/mt.2015.199 – ident: e_1_3_2_45_2 doi: 10.1073/pnas.2216352120 – ident: e_1_3_2_106_2 doi: 10.1073/pnas.2203247119 – ident: e_1_3_2_55_2 doi: 10.1073/pnas.232058599 – ident: e_1_3_2_7_2 doi: 10.1056/NEJMoa1407222 – ident: e_1_3_2_107_2 doi: 10.1038/srep10082 – ident: e_1_3_2_100_2 doi: 10.1172/JCI159402 – ident: e_1_3_2_27_2 doi: 10.1038/s41587-023-01687-x – ident: e_1_3_2_102_2 doi: 10.1038/s41467-021-25282-3 – ident: e_1_3_2_40_2 doi: 10.1158/1535-7163.MCT-19-1109 – ident: e_1_3_2_104_2 doi: 10.4049/jimmunol.174.4.1898 – ident: e_1_3_2_35_2 doi: 10.1158/0008-5472.CAN-15-0159 – ident: e_1_3_2_70_2 doi: 10.1084/jem.190.5.617 – ident: e_1_3_2_12_2 doi: 10.1126/scitranslmed.3008226 – ident: e_1_3_2_41_2 doi: 10.1038/s41586-022-04585-5 – ident: e_1_3_2_6_2 doi: 10.1016/S0140-6736(14)61403-3 – ident: e_1_3_2_28_2 doi: 10.1002/cpt.2040 – ident: e_1_3_2_4_2 doi: 10.1038/d41573-021-00100-z – ident: e_1_3_2_30_2 doi: 10.1002/psp4.12388 – ident: e_1_3_2_48_2 doi: 10.1073/pnas.1716266115 – ident: e_1_3_2_103_2 doi: 10.1038/s41586-019-1054-1 – ident: e_1_3_2_62_2 doi: 10.1038/nature17412 – ident: e_1_3_2_9_2 doi: 10.1126/scitranslmed.3005930 – ident: e_1_3_2_122_2 doi: 10.1038/s41375-020-0792-2 – ident: e_1_3_2_85_2 doi: 10.1083/jcb.201406121 – ident: e_1_3_2_113_2 doi: 10.1126/science.abp8933 – ident: e_1_3_2_64_2 doi: 10.1038/88765 – ident: e_1_3_2_117_2 doi: 10.1083/jcb.139.3.759 – ident: e_1_3_2_33_2 doi: 10.1158/0008-5472.CAN-15-0139 – ident: e_1_3_2_17_2 doi: 10.1016/j.jtct.2022.09.006 – ident: e_1_3_2_54_2 doi: 10.4049/jimmunol.169.6.2837 – ident: e_1_3_2_29_2 doi: 10.1158/1078-0432.CCR-18-0758 – ident: e_1_3_2_95_2 doi: 10.1016/j.ccell.2015.09.004 – ident: e_1_3_2_15_2 doi: 10.1038/s41417-023-00593-3 – ident: e_1_3_2_60_2 doi: 10.4049/jimmunol.173.9.5392 – ident: e_1_3_2_42_2 doi: 10.1126/scitranslmed.abh1962 – ident: e_1_3_2_78_2 doi: 10.1016/j.ccell.2022.04.001 – ident: e_1_3_2_96_2 doi: 10.1006/bbrc.1997.8016 – ident: e_1_3_2_66_2 doi: 10.1038/s41591-022-01959-0 – ident: e_1_3_2_53_2 doi: 10.1128/MCB.00160-10 – ident: e_1_3_2_36_2 doi: 10.1038/s41375-022-01585-2 – ident: e_1_3_2_69_2 doi: 10.1172/jci.insight.99048 – ident: e_1_3_2_71_2 doi: 10.1038/sj.icb.7100045 – ident: e_1_3_2_120_2 doi: 10.1038/ncomms16001 – ident: e_1_3_2_73_2 doi: 10.1083/jcb.141.4.929 |
| SSID | ssj0001466519 |
| Score | 2.303682 |
| Snippet | Chimeric antigen receptor T cells (CART) targeting CD19 through CD28.ζ signaling induce rapid lysis of leukemic blasts, contrasting with persistent tumor... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | eadq8114 |
| SubjectTerms | CD28 Antigens - immunology CD28 Antigens - metabolism Cell Line, Tumor Cytotoxicity, Immunologic Humans Immunological Synapses - immunology Immunological Synapses - metabolism Immunotherapy, Adoptive - methods Membrane Microdomains - metabolism Molecular Dynamics Simulation Receptors, Chimeric Antigen - immunology Receptors, Chimeric Antigen - metabolism Signal Transduction T-Lymphocytes - immunology T-Lymphocytes - metabolism Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology Tumor Necrosis Factor Receptor Superfamily, Member 9 - metabolism |
| Title | Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39792660 https://www.proquest.com/docview/3154148510 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEA6iFy_i2_XFCIJ6qLSbttseRBZRF2E9yC7sreYxgYVlX63i_nsnbeoDFbz0UMKETjLN9yWT-Rg75UolhqeBlzZlSgQlQk-mIvIIWkvhx2h0eaLbfYw7_fBhEA0-85-cA_NfqZ3Vk-rPR5dvs8U1BfzVlwswQr9eCj1LAqtpvVKeFdk0Pgf1y_2WMI6jUuejyVuRR7wocTUcf5r4vkb9ATzLBehuna055Ajtaqg32BKON9mGi80czl0B6Yst9tytNW9BV4LzOYgChvYqCEJOr6Y5wmg4HWqYC1PkMKylSoDwIKhFMRktqBuoL_HDxMBN-wl6YDf6823Wv7vt3XQ8p6TgKc6jwkNCBYRkQoPK2AJi3Njs_0BJSQgilMiFFjrQrVC1fJ2qVpqEoY_oS5lIxDjlO2x5PBnjHgMRGaJMqAVHYtVSCW601PSjCEVEtniDebXvMuXKjFu1i1FW0o1mnFW-zpyvG-zso_20KrDxZ8uTeigyigH7vWKMk5c844EVMyfs6DfYbjVGH7bsuSWBEH__3_0csNWmFfn1ba7fIVsu5i94RMijkMclY6fn_SA4LqfXO-Ex3EY |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+dynamics+at+immune+synapse+lipid+rafts+influence+the+cytolytic+behavior+of+CAR+T+cells&rft.jtitle=Science+advances&rft.au=Gad%2C+Ahmed+Z.&rft.au=Morris%2C+Jessica+S.&rft.au=Godret-Miertschin%2C+Lea&rft.au=Montalvo%2C+Melisa+J.&rft.date=2025-01-10&rft.issn=2375-2548&rft.eissn=2375-2548&rft.volume=11&rft.issue=2&rft_id=info:doi/10.1126%2Fsciadv.adq8114&rft.externalDBID=n%2Fa&rft.externalDocID=10_1126_sciadv_adq8114 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2375-2548&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2375-2548&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2375-2548&client=summon |